Who is sponsoring NCT03868306?

NCT03868306 is sponsored by Assiut University.

What drugs are being tested in NCT03868306?

Interventions in NCT03868306: CBC , Iron study and Haemoglobin electrophoresis ..

What condition does NCT03868306 study?

NCT03868306 studies Microcytic Hypochromic Anemia.

Is NCT03868306 still recruiting?

NCT03868306 is currently status unknown. Last updated 11 March 2019.

Last reviewed 2019-03-11 · How we verify

NCT03868306

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Red Cell Distribution Width Index Versus Red Cell Distribution Width as Discriminating Guide for Iron Deficiency Anaemia and Beta Thalassemia Trait .

Status unknown Last updated 11 March 2019

What this trial tests

trial testing CBC , Iron study and Haemoglobin electrophoresis . in Microcytic Hypochromic Anemia in 100 participants. Status unknown.

Timeline

1 June 2019

Primary endpoint
1 June 2020

1 June 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 June 2019
Primary completion	1 June 2020
Estimated completion	1 June 2022

Drugs / interventions tested

CBC , Iron study and Haemoglobin electrophoresis .

Conditions studied

Microcytic Hypochromic Anemia — all drugs for Microcytic Hypochromic Anemia →

Sponsor

Assiut University

Who can join

Adults 2 to 18, any sex, with Microcytic Hypochromic Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Red Cell Distribution Width Index versus Red Cell Distribution Width as Discriminating Guide for Iron Deficiency Anaemia and Beta Thalassemia Trait .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03868306 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 11 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03868306.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing